MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...